Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in KYTX — Kyverna Therapeutics, Inc.

CIK 80255 BALTIMORE, MD
Back to KYTX Full portfolio

Position in KYTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$10,567,464
-$2,854,662 QoQ
Shares Held
1,186,023
-23.7% QoQ
Ownership
1.92%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 120 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KYTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. KYTX ranks #116 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 2,678,047 $2,484,611,664
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,529,709 $953,834,749
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,728,421 $858,558,562
4 KYMR
Kymera Therapeutics, Inc.
 7,112,980 $815,645,416
5 RPRX
Royalty Pharma plc
 11,193,657 $627,628,347
6 RVMD
Revolution Medicines, Inc.
 2,969,853 $447,655,945
7 MRNA
Moderna, Inc.
 5,589,560 $391,436,886
8 TWST
Twist Bioscience Corp
 3,634,652 $373,932,997

All Filings in KYTX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,567,464 1,186,023
2026-03-31 $13,422,126 1,555,287
2025-12-31 $16,568,599 1,762,617
2025-09-30 $9,073,194 1,512,199
2025-06-30 $5,619,637 1,830,501
2025-03-31 $1,118,635 579,604
2024-12-31 $2,220,392 593,688
2024-09-30 $3,072,005 628,222
2024-06-30 $5,021,677 669,557
2024-03-31 $23,092,107 929,634